News
Crystal Pharmatech Launches OEB4/OEB5 High-Potency Laboratory, Expanding Global CDMO Capabilities for Complex Drug Development
02 Apr 2026
While tablets and capsules remain the most common formats, we manage the complexities of modern OSD development for asset-light, R&D-focused Biotech firms.
High-quality results with limited API supply at early stages.
Accelerating development to meet critical clinical milestones.
Predicting commercial-scale parameters using only grams of material.
| Dosage Forms | Manufacturing Processes |
|---|---|
| Tablets IR, CR, Bilayer, Enteric-coated and Mini-tablets. | Granulation Wet, Dry, Milling, SD, HME, and Blending. |
| Capsules Powder, Granules, and Multi-particulates. | Finishing Compression, Encapsulation, and Film Coating. |
Subscribe to be the first to get the updates!